FKBPL/WISP39 has been associated with cancer, regulation of tumour growth and angiogenesis, its high expression being positively evaluated for improved patient survival [170], most likely due to stabilization of newly synthesised cyclin-dependent kinase inhibitor, p21. Here, FKBPL is linked to cancer.